Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 4.724.173.644.064.38

What is the latest Core EBITDA Margin ratio of TTK HEALTHCARE ?

The latest Core EBITDA Margin ratio of TTK HEALTHCARE is 4.72 based on Mar2024 Standalone results.
Year Core EBITDA Margin
Mar20244.72
Mar20234.17
Mar20223.64
Mar20214.06
Mar20204.38

How is Core EBITDA Margin of TTK HEALTHCARE Trending?

Years Core EBITDA Margin % Change
Mar2024 4.72
13.19
Mar2023 4.17
14.56
Mar2022 3.64
-10.34
Mar2021 4.06
-7.31
Mar2020 4.38 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Margin ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,855.3 Cr -4% -10.3% 0.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,533.0 Cr -1.2% 0.9% 41.4% Stock Analytics
DIVIS LABORATORIES ₹153,076.0 Cr -3.7% -1.8% 46.1% Stock Analytics
CIPLA ₹118,723.0 Cr -1.5% 2.2% 16.2% Stock Analytics
DR REDDYS LABORATORIES ₹112,998.0 Cr 1.4% 10.6% 17.2% Stock Analytics
ZYDUS LIFESCIENCES ₹101,031.0 Cr 3.5% 3.6% 37.4% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-4%

-10.3%

0.9%

SENSEX

-2.3%

-5.1%

7.4%


You may also like the below Video Courses